Clinical Trials for Mesothelioma Patients—A Study to Find the Best Dose of SU011248: Contact Information
Read about the contact information for a current clinical trial about the use of SU011248 for patients with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.
Contacts and Locations:
Contact: Pfizer Oncology Clinical Trial Information Service
1-877-369-9753
PfizerCancerTrials@emergingmed.com
Pfizer Investigational Site:
Aurora, Colorado
Denver, Colorado
Ottawa, Ontario, Canada, K1H 8L6
Montreal, Quebec, Canada, H2L 4M1
Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health
If you or a loved one has been diagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.

Outcome measures for study of SU011248 against mesothelioma tumors